Merry christmas to all holders.
I believe 2011 will gut wrench and stir us. I believe we will savour success . First quarter is just around the corner. By then the American trials will complete, and show up the only potent vascular disrupting agent advantage.
As for the french trials of anxiolitics, the study is so tightly constructed that a multi facetted guideline will allow fast tracking towards clear success. I believe accelaration to commercialisation likely.
I base all this not on any known results, but on balance of probability. I have kept abreast of reports, read in detail, and am satisfied that a no nonsense team is on the best possible track.
Good luck and christmas cheer to holders
Add to My Watchlist
What is My Watchlist?